United States · Series D startup

Who invested in SpyGlass Pharma

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

DeliveryHealthtech

Funding summaryUpdated 26 Oct 2026

$165Mraised across 2 rounds since 2023, from 3 sources

$90MSeries C$75MSeries D

Latest round: Series D, $75MJun 2025
Biggest round: $90MSeries C · Jul 2023
Investors: 4

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20242025

$90MSeries C$75MSeries D

First round: Series C, $90M
Biggest round: $90M
Between rounds: 23 months

The rounds

Jun 2025
Series D$75M4 new
Reported by Vensana Capital and 1 other
Jul 2023
Series C$90M
No investor was named in the report.
Reported by Vensana Capital

Founders and team

From SpyGlass Pharma's own website: 11 on the team.

Patrick MooneyChief Executive Officer
Laurie MellottVice President, Clinical Operations
Mike PinderVice President, Marketing
Nina NguyenSenior Vice President, Regulatory & Quality
Paul YooSenior Vice President, Clinical Development
James DennewillChief Operating Officer
Jean-Frédéric ViretChief Financial Officer
Elizabeth O’FarrellBoard Director
Geoff PardoBoard Director, Gilde Healthcare US
Habib J. DableBoard Director
SkyVision CentersBoard Advisors

AdvisersAziz MottiwalaDavid Van Meter

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series C2023Series D2025

New Enterprise Associates

RA Capital Management

Samsara BioCapital

Sands Capital Ventures

Everyone who backed them

New Enterprise AssociatesVC firm1round

RA Capital ManagementPrivate equity1round

Samsara BioCapitalVC firm1round

Sands Capital VenturesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about SpyGlass Pharma

Who invested in SpyGlass Pharma?

SpyGlass Pharma's investors include New Enterprise Associates, RA Capital Management, Samsara BioCapital and Sands Capital Ventures.

How much has SpyGlass Pharma raised?

SpyGlass Pharma has raised $165M across 2 rounds since 2023.

When did SpyGlass Pharma last raise?

SpyGlass Pharma's most recent round was a Series D of $75M in Jun 2025.

What was SpyGlass Pharma's biggest round?

SpyGlass Pharma's largest round on record is $90M (Series C), in Jul 2023.

Who backed SpyGlass Pharma first?

SpyGlass Pharma's first round on record, in Jun 2025, was backed by New Enterprise Associates, RA Capital Management and Samsara BioCapital and 1 others.